Skip NavigationMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting Club
PRO
LivestreamMenu
Elsa Ohlen is a companies reporter at CNBC International in London, covering earnings, strategy shifts, leadership changes, and industry trends.
read more
Latest
Novo Nordisk rolls out Wegovy pill in the UAE — its first market outside the U.S.Elsa Ohlen1 Hour AgoBiotech takeover target Abivax sinks 43% as cancer cases cloud trial data for bowel disease drugElsa OhlenJune 2, 2026How the ‘double scar’ of past inflation woes and geopolitical shocks is hitting consumersElsa OhlenMay 29, 2026‘King of Cashmere’ CEO on outperforming the luxury slowdown: Don’t be greedyElsa OhlenMay 28, 2026‘Europe doesn’t realize how dangerous it is’: Telecoms CEO warns of U.S. dominance in satellites, AIElsa OhlenMay 21, 2026A strange paradox has taken hold of the global fashion industryElsa OhlenMay 20, 2026NATO’s newest member Sweden announces $4 billion defense investment; Saab pops 5%Elsa OhlenMay 19, 2026Weight-loss wars go global as Novo Nordisk bets big on its Wegovy pillElsa OhlenMay 18, 2026Magnum Ice Cream stock soars after report of potential private equity takeoverElsa OhlenMay 15, 2026Polestar CEO tells CNBC ‘pump anxiety’ has made EVs ‘all about money’Elsa OhlenMay 14, 2026Burberry stock drops even as Americas and China demand boost turnaround effortsElsa OhlenMay 14, 2026European markets close higher, UK gilts volatile as pressure mounts on PM StarmerElsa Ohlen|Joseph WilkinsMay 13, 2026
About The Author
